Carbamoyloxylabdanes

Details Carbamoyloxylabdanes Carbamoyloxylabdanes

1993-03-25

1994-12-20

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5142282, 5142328, 514253, 5142325, 514365, 514374, 514434, 514435, 514452, 514453, 5142285, 544 60, 544150, 544378, 546197, 548146, 548215, 5483415, 548526, 549 15, 549 18, 549358, 549387, A61K 3141, A61K 3136, C07D23920, C07D31908

Patent

active

053746503

ABSTRACT:
Novel carbamoyloxylabdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure and treating cardiac failure utilizing compounds and compositions thereof are disclosed.

REFERENCES:
patent: 3631039 (1971-12-01), Andrews
patent: 4088659 (1978-05-01), Bhat et al.
patent: 4118508 (1978-10-01), Bhat et al.
patent: 4134986 (1979-01-01), Bajwa et al.
patent: 4476140 (1984-10-01), Sears
patent: 4517200 (1985-05-01), Kreutner et al.
patent: 4564626 (1986-01-01), Kreutner et al.
patent: 4639443 (1987-01-01), Kosley et al.
patent: 4639446 (1987-01-01), Kosley
patent: 4920146 (1990-04-01), Kosley, Jr. et al.
patent: 5093336 (1992-03-01), Kosley, Jr. et al.
A. Laurenza, et al., Molecular Pharmacology, 32, 133 (1987).
CALBIOCHEM Biochemical/Immunochemical Catalog, 1988 New Product supplement, p. 18.
S. P. Bartels, et al., Current Eye Research, 2, 673 (Feb. 1983).
R. J. Cherill, et al., Abstracts of Papers, 192nd ACS National Meeting, Medi, No. 48 (Sep. 1986).
J. Caprioli and M. Sears, The Yale Journal of Biology and Medicine, 57, 283 (1984).
K. B. Seamon and J. W., Daly, Trends in Pharmacological Sciences, 48,120 (1983).
K. B. Seamon and J. W. Daly, J., Cyclic Nucleotide Research, 7, 201 (1981).
J. Caprioli, et al., Abstracts, Association for Research in Vision and Ophthalmology, 233 (1986).
S. P. Bartels, et al., Current Eye Research, 6, 307 (1987).
K. B. Seamon and J. W. Daly, in "Advances in Cyclic Nucleotide and Protein Phosphorylation Research", vol. 20, P. Greengard and G. A. Robison, Editors, Raven Press, New York, N.Y., 1986, pp. 1 to 150.
N. J. de Sousa, et al., Medicinal Research Reviews, 3, 201 (1983).
S. V. Bhat, et al., J. Med. Chem.,26,486 (1983).
K. B. Seamon, et al., J. Med. Chem.,26, 436 (1983).
S. V. Bhat, et al., Tetrahedron Letters, 1669 (1977).
S. V. Bhat, et al., J. C. S. Perkin I, 767 (1982).
J. Caprioli, et al., Investigative Ophthalmology and Visual Science, 25, 268 (1984).
J. Caprioli and M. Sears, The Lancet, 958 (1983).
K. B. Seamon, et al., Proc. Natl. Acad. Sci, USA 78, 3363 (1981).
K. Seamon and J. W. Daly, The Journal of Biological Chemistry, 256, 9799(1981).
J. Takeda, et al., The Journal of Investigative Dermatology, 81, 236 (1983).
J. Takeda, et al., The Journal of Investigative Dermatology, 81, 131 (1983).
H. Hzuka, et al., Biochimica et Biophysica Acta., 444, 685 (1976).
H. Hzuka, et al., Biochimica et Biophysica Acta., 437,150 (1976).
J. J. Voorhees, The Journal of Investigative Dermatology, 59, 114 (1972).
K. M. Halprin, et al., The Journal of Investigative Dermatology, 65, 170 (1975).
W. P. Raab, International Journal of Clinical Pharmacology, Therapy and Toxicology, 18, 212 (1980).

Affiliated with

Also associated with

Rating

Carbamoyloxylabdanes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carbamoyloxylabdanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamoyloxylabdanes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2386421